Search Results

There are 35392 results for: content related to: Is Prevention the Best Treatment? CMV After Lung Transplantation

  1. You have free access to this content
    Retrospective review of the incidence of cytomegalovirus infection and disease after liver transplantation in pediatric patients: Comparison of prophylactic oral ganciclovir and oral valganciclovir

    Liver Transplantation

    Volume 18, Issue 3, March 2012, Pages: 347–354, Ashley N. Bedel, Trina S. Hemmelgarn and Rohit Kohli

    Article first published online : 24 FEB 2012, DOI: 10.1002/lt.22471

  2. You have free access to this content
    Polyfunctional Cytomegalovirus-Specific Immunity in Lung Transplant Recipients Receiving Valganciclovir Prophylaxis

    American Journal of Transplantation

    Volume 11, Issue 3, March 2011, Pages: 553–560, L. D. Snyder, R. Medinas, C. Chan, S. Sparks, W. A Davis, S. M. Palmer and K. J. Weinhold

    Article first published online : 10 JAN 2011, DOI: 10.1111/j.1600-6143.2010.03405.x

  3. You have free access to this content
    Primary CMV Infections Are Common in Kidney Transplant Recipients After 6 Months Valganciclovir Prophylaxis

    American Journal of Transplantation

    Volume 10, Issue 9, September 2010, Pages: 2026–2032, I. Helanterä, L. Kyllönen, I. Lautenschlager, K. Salmela and P. Koskinen

    Article first published online : 27 AUG 2010, DOI: 10.1111/j.1600-6143.2010.03225.x

  4. You have free access to this content
    Valganciclovir: Recent Progress

    American Journal of Transplantation

    Volume 10, Issue 6, June 2010, Pages: 1359–1364, M. D. Pescovitz

    Article first published online : 28 APR 2010, DOI: 10.1111/j.1600-6143.2010.03112.x

  5. You have free access to this content
    Following Universal Prophylaxis with Intravenous Ganciclovir and Cytomegalovirus Immune Globulin, Valganciclovir is Safe and Effective for Prevention of CMV Infection Following Lung Transplantation

    American Journal of Transplantation

    Volume 4, Issue 10, October 2004, Pages: 1635–1642, Martin R. Zamora, Mark R. Nicolls, Tony N. Hodges, Jane Marquesen, Todd Astor, Todd Grazia and David Weill

    Article first published online : 20 JUL 2004, DOI: 10.1111/j.1600-6143.2004.00571.x

  6. Sequential treatment of cytomegalovirus infection or disease with a short course of intravenous ganciclovir followed by oral valganciclovir: efficacy, safety, and pharmacokinetics

    Transplant Infectious Disease

    Volume 12, Issue 3, June 2010, Pages: 204–212, A. Caldés, S. Gil-Vernet, Y. Armendariz, H. Colom, L. Pou, J. Niubó, L. Lladó, J. Torras, N. Manito, G. Rufí and J.M. Grinyó

    Article first published online : 9 DEC 2009, DOI: 10.1111/j.1399-3062.2009.00481.x

  7. You have free access to this content
    Antiviral medications for preventing cytomegalovirus disease in solid organ transplant recipients

    Intervention Review

    The Cochrane Library

    Elisabeth M Hodson, Maleeka Ladhani, Angela C Webster, Giovanni FM Strippoli and Jonathan C Craig

    Published Online : 28 FEB 2013, DOI: 10.1002/14651858.CD003774.pub4

  8. You have free access to this content
    Efficacy and Safety of Valganciclovir vs. Oral Ganciclovir for Prevention of Cytomegalovirus Disease in Solid Organ Transplant Recipients

    American Journal of Transplantation

    Volume 4, Issue 4, April 2004, Pages: 611–620, Carlos Paya, Atul Humar, Ed Dominguez, Kenneth Washburn, Emily Blumberg, Barbara Alexander, Richard Freeman, Nigel Heaton, Mark D. Pescovitz and Valganciclovir Solid Organ Transplant Study Group

    Article first published online : 25 FEB 2004, DOI: 10.1111/j.1600-6143.2004.00382.x

  9. You have free access to this content
    Six months anti-viral prophylaxis significantly decreased cytomegalovirus disease compared with no anti-viral prophylaxis following renal transplantation

    Transplant International

    Volume 23, Issue 9, September 2010, Pages: 897–906, Francesca Leone, Ahmed Akl, Magali Giral, Jacques Dantal, Gilles Blancho, Jean-Paul Soulillou and Diego Cantarovich

    Article first published online : 10 MAR 2010, DOI: 10.1111/j.1432-2277.2010.01073.x

  10. You have free access to this content
    A Multicenter Study of Valganciclovir Prophylaxis up to Day 120 in CMV-Seropositive Lung Transplant Recipients

    American Journal of Transplantation

    Volume 9, Issue 5, May 2009, Pages: 1134–1141, V. Monforte, C. Lopez, F. Santos, F. Zurbano, M. De La Torre, A. Sole, J. Gavalda, P. Ussetti, R. Lama, J. Cifrian, J. M. Borro, A. Pastor, O. Len, C. Bravo and A. Roman

    Article first published online : 16 MAR 2009, DOI: 10.1111/j.1600-6143.2009.02574.x

  11. Cytomegalovirus disease and infection in lung transplant recipients in the setting of planned indefinite valganciclovir prophylaxis

    Transplant Infectious Disease

    Volume 14, Issue 3, June 2012, Pages: 248–258, A.P. Wiita, N. Roubinian, Y. Khan, P.V. Chin-Hong, J.P. Singer, J.A. Golden and S. Miller

    Article first published online : 5 MAR 2012, DOI: 10.1111/j.1399-3062.2012.00723.x

  12. Efficacy and Safety of Low-Dose Valganciclovir for Prevention of Cytomegalovirus Disease in Renal Transplant Recipients: A Single-Center, Retrospective Analysis

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 24, Issue 10, October 2004, Pages: 1323–1330, Dr. Steven Gabardi, Dr. Colm C. Magee, Dr. Steven A. Baroletti, Dr. John A. Powelson, Dr. Jennifer L. Cina and Dr. Anil K. Chandraker

    Article first published online : 16 JAN 2012, DOI: 10.1592/phco.24.14.1323.43152

  13. You have free access to this content
    AMERICAN TRANSPLANT CONGRESS 2012 ABSTRACTS

    American Journal of Transplantation

    Volume 12, Issue s3, May 2012, Pages: 27–542,

    Article first published online : 26 APR 2012, DOI: 10.1111/j.1600-6143.2012.04112.x

  14. You have free access to this content
    Prevention of Posttransplant Cytomegalovirus Disease and Related Outcomes with Valganciclovir: A Systematic Review

    American Journal of Transplantation

    Volume 8, Issue 10, October 2008, Pages: 2111–2118, H-Y. Sun, M. M. Wagener and N. Singh

    Article first published online : 16 SEP 2008, DOI: 10.1111/j.1600-6143.2008.02369.x

  15. Pharmacokinetics of oral valganciclovir solution and intravenous ganciclovir in pediatric renal and liver transplant recipients

    Transplant Infectious Disease

    Volume 12, Issue 3, June 2010, Pages: 195–203, M.D. Pescovitz, R.B. Ettenger, C.F. Strife, J.R. Sherbotie, S.E. Thomas, S. McDiarmid, S. Bartosh, J. Ives, M.R. Bouw and J. Bucuvalas

    Article first published online : 7 DEC 2009, DOI: 10.1111/j.1399-3062.2009.00478.x

  16. Valganciclovir: A New Oral Alternative for Cytomegalovirus Retinitis in Human Immunodeficiency Virus-Seropositive Individuals

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 22, Issue 9, September 2002, Pages: 1124–1128, Dr. Marisel Segarra-Newnham and Dr. Martha I. Salazar

    Article first published online : 17 JAN 2012, DOI: 10.1592/phco.22.13.1124.33527

  17. The efficacy and safety of valganciclovir vs. oral ganciclovir in the prevention of symptomatic CMV infection in children after solid organ transplantation

    Pediatric Transplantation

    Volume 14, Issue 6, September 2010, Pages: 753–760, E. Lapidus-Krol, R. Shapiro, J. Amir, M. Davidovits, R. Steinberg, E. Mor and Y. Avitzur

    Article first published online : 3 MAY 2010, DOI: 10.1111/j.1399-3046.2010.01330.x

  18. You have free access to this content
    The Efficacy and Safety of 200 Days Valganciclovir Cytomegalovirus Prophylaxis in High-Risk Kidney Transplant Recipients

    American Journal of Transplantation

    Volume 10, Issue 5, May 2010, Pages: 1228–1237, A. Humar, Y. Lebranchu, F. Vincenti, E. A. Blumberg, J. D. Punch, A. P. Limaye, D. Abramowicz, A. G. Jardine, A. T. Voulgari, J. Ives, I. A. Hauser and P. Peeters

    Article first published online : 26 MAR 2010, DOI: 10.1111/j.1600-6143.2010.03074.x

  19. You have free access to this content
    Prophylactic Versus Preemptive Oral Valganciclovir for the Management of Cytomegalovirus Infection in Adult Renal Transplant Recipients

    American Journal of Transplantation

    Volume 6, Issue 9, September 2006, Pages: 2134–2143, J. A. Khoury, G. A. Storch, D. L. Bohl, R. M. Schuessler, S. M. Torrence, M. Lockwood, M. Gaudreault-Keener, M. J. Koch, B. W. Miller, K. L. Hardinger, M. A. Schnitzler and D. C. Brennan

    Article first published online : 19 JUN 2006, DOI: 10.1111/j.1600-6143.2006.01413.x

  20. Population pharmacokinetics of valganciclovir prophylaxis in paediatric and adult solid organ transplant recipients

    British Journal of Clinical Pharmacology

    Volume 78, Issue 2, August 2014, Pages: 343–352, Heather E. Vezina, Richard C. Brundage and Henry H. Balfour Jr

    Article first published online : 21 JUL 2014, DOI: 10.1111/bcp.12343